Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK.
BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
Pulmonary Hypertension Associated with Connective Tissue Disease.
Mathai SC.
Cardiol Clin. 2022 Feb;40(1):29-43. doi: 10.1016/j.ccl.2021.08.003.
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
Thoreau B, Mouthon L.
Autoimmun Rev. 2024 Apr;23(4):103506. doi: 10.1016/j.autrev.2023.103506. Epub 2023 Dec 21.
Pulmonary Hypertension Associated with Connective Tissue Disease.
Mathai SC.
Rheum Dis Clin North Am. 2024 Aug;50(3):359-379. doi: 10.1016/j.rdc.2024.03.005.
Pulmonary Hypertension Associated with Connective Tissue Disease.
Fayed H, Coghlan JG.
Semin Respir Crit Care Med. 2019 Apr;40(2):173-183. doi: 10.1055/s-0039-1685214. Epub 2019 May 28.
Interstitial Lung Disease: A Review.
Maher TM.
JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669.
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ, Korkmaz C.
Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17.
Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Kularatne M, Boucly A, Savale L, Solinas S, Cheron C, Roche A, Jevnikar M, Jaïs X, Montani D, Humbert M, Sitbon O.
Expert Opin Pharmacother. 2023 Sep-Dec;24(18):2101-2115. doi: 10.1080/14656566.2023.2273395. Epub 2024 Jan 5.
Pulmonary hypertension phenotypes in patients with systemic sclerosis.
Haque A, Kiely DG, Kovacs G, Thompson AAR, Condliffe R.
Eur Respir Rev. 2021 Aug 17;30(161):210053. doi: 10.1183/16000617.0053-2021. Print 2021 Sep 30.
Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis.
Erdogan M, Esatoglu SN, Kilickiran Avci B, Hatemi G.
Intern Emerg Med. 2024 Apr;19(3):731-743. doi: 10.1007/s11739-024-03539-1. Epub 2024 Feb 20.
